Bipolar Research Today is a free monthly online journal that collates and summarizes the latest research about Bipolar, including details on bipolar disorder, symptoms, treatment, depression, medication.

Volume 8 (2011), Issue 7 (July)

1. Lithium decreases VEGF mRNA expression in leukocytes of healthy subjects and patients with bipolar disorder.
   Hum Psychopharmacol. [Abstract] [Full-text]
2. Detection of bipolar disorder.
   Br J Psychiatry, 199: 3-4. [Abstract] [Full-text]
3. The efficacy of N-acetylcysteine as an adjunctive treatment in bipolar depression: An open label trial.
   J Affect Disord. [Abstract] [Full-text]
4. Valproate v. lithium in the treatment of bipolar disorder in clinical practice: observational nationwide register-based cohort study.
   Br J Psychiatry, 199: 57-63. [Abstract] [Full-text]
5. Role of COMT, 5-HT(1A) , and SERT genetic polymorphisms on antidepressant response to Transcranial Magnetic Stimulation.
   Depress Anxiety, 28(7): 568-73. [Abstract] [Full-text]
6. Unrecognised bipolar disorder in primary care patients with depression.
   Br J Psychiatry, 199: 49-56. [Abstract] [Full-text]
7. Differences in temperament and character dimensions in patients with bipolar I or II or major depressive disorder and general population subjects.
   Psychol Med, 41(8): 1579-91. [Abstract] [Full-text]
8. Personality and bipolar disorder: dissecting state and trait associations between mood and personality.
   Psychol Med, 41(8): 1593-604. [Abstract] [Full-text]
9. A comprehensive review and model of putative prodromal features of bipolar affective disorder.
   Psychol Med, 41(8): 1567-77. [Abstract] [Full-text]
10. A learning collaborative of CMHCs and CHCs to support integration of behavioral health and general medical care.
    Psychiatr Serv, 62(7): 753-8. [Abstract] [Full-text]
11. Relationship of trait impulsivity with clinical presentation in euthymic bipolar disorder patients.
    Psychiatry Res. [Abstract] [Full-text]
12. Therapeutic use of omega-3 fatty acids in bipolar disorder.
    Expert Rev Neurother, 11(7): 1029-47. [Abstract] [Full-text]
13. Insulin dysfunction and allostatic load in bipolar disorder.
    Expert Rev Neurother, 11(7): 1017-28. [Abstract] [Full-text]
14. Chronobiological therapy for mood disorders.
    Expert Rev Neurother, 11(7): 961-70. [Abstract] [Full-text]
15. Neurochemical alteration in the caudate: implications for the pathophysiology of bipolar disorder.
    Psychiatry Res, 193(2): 107-12. [Abstract] [Full-text]
16. Toward a functional neuroanatomical signature of bipolar disorder: quantitative evidence from the neuroimaging literature.
    Psychiatry Res, 193(2): 71-9. [Abstract] [Full-text]
17. Discriminating schizophrenia and bipolar disorder by fusing fMRI and DTI in a multimodal CCA+ joint ICA model.
    Neuroimage, 57(3): 839-55. [Abstract] [Full-text]
18. Structural neuroimaging studies in major depressive disorder. Meta-analysis and comparison with bipolar disorder.
    Arch Gen Psychiatry, 68(7): 675-90. [Abstract] [Full-text]
19. Second generation antipsychotics (SGAs) for non-psychotic disorders in children and adolescents: a review of the randomized controlled studies.
    Eur Neuropsychopharmacol, 21(8): 600-20. [Abstract] [Full-text]
20. Decreased neuronal Na+, K+ -ATPase activity in Atp1a3 heterozygous mice increases susceptibility to depression-like endophenotypes by chronic variable stress.
    Genes Brain Behav, 10(5): 542-50. [Abstract] [Full-text]
21. Efficacy and safety of second-generation antipsychotics in children and adolescents with psychotic and bipolar spectrum disorders: comprehensive review of prospective head-to-head and placebo-controlled comparisons.
    Eur Neuropsychopharmacol, 21(8): 621-45. [Abstract] [Full-text]
22. Neuroanatomical correlates of suicide in psychosis: the possible role of von economo neurons.
    PLoS One, 6(6): e20936. [Abstract] [Full-text]
23. Hypomanic switching during influenza infection without intracranial infection in an adolescent patient with bipolar disorder.
    Pediatr Emerg Care, 27(7): 652-3. [Abstract] [Full-text]
24. The T allele of the interferon-gamma +874A/T polymorphism is associated with bipolar disorder.
    Nord J Psychiatry. [Abstract] [Full-text]
25. Factors associated with the course of symptoms in bipolar disorder during a 1-year follow-up: Depression vs. sub-threshold mixed state.
    Nord J Psychiatry. [Abstract] [Full-text]
26. A Rare Case of Acute Respiratory Distress Syndrome Secondary to Acute Lithium Intoxication.
    Am J Ther. [Abstract] [Full-text]
27. Mouse strain differences in phencyclidine-induced behavioural changes.
    Int J Neuropsychopharmacol. [Abstract] [Full-text]
28. Lamotrigine blocks NMDA receptor-initiated arachidonic acid signalling in rat brain: implications for its efficacy in bipolar disorder.
    Int J Neuropsychopharmacol. [Abstract] [Full-text]
29. Caring for older adults with bipolar disorder.
    J Psychosoc Nurs Ment Health Serv, 49(7): 21-5. [Abstract] [Full-text]
30. Relationship of persistent manic symptoms to the diagnosis of pediatric bipolar spectrum disorders.
    J Clin Psychiatry, 72(6): 846-53. [Abstract] [Full-text]
31. Increased olanzapine discontinuation and health care resource utilization following a Medicaid policy change.
    J Clin Psychiatry, 72(6): 787-94. [Abstract] [Full-text]
32. Levetiracetam in the management of bipolar depression: a randomized, double-blind, placebo-controlled trial.
    J Clin Psychiatry, 72(6): 744-50. [Abstract] [Full-text]
33. Acute efficacy of divalproex sodium versus placebo in mood stabilizer-naive bipolar I or II depression: a double-blind, randomized, placebo-controlled trial.
    J Clin Psychiatry, 72(6): 813-9. [Abstract] [Full-text]
34. Genome-wide association of bipolar disorder suggests an enrichment of replicable associations in regions near genes.
    PLoS Genet, 7(6): e1002134. [Abstract] [Full-text]
35. Neuroprotective action of lithium in disorders of the central nervous system.
    Zhong Nan Da Xue Xue Bao Yi Xue Ban, 36(6): 461-76. [Abstract] [Full-text]
36. N-acetyl cysteine restores brain glutathione loss in combined 2-cyclohexene-1-one and D-amphetamine-treated rats: relevance to schizophrenia and bipolar disorder.
    Neurosci Lett, 499(3): 149-53. [Abstract] [Full-text]
37. Substance use and HIV risk in a sample of severely mentally Ill Puerto Rican women.
    J Immigr Minor Health, 13(4): 681-9. [Abstract] [Full-text]
38. Improving tolerability of lithium with a once-daily dosing schedule.
    Am J Ther, 18(4): 288-91. [Abstract] [Full-text]
39. Association between genetic variation in a region on chromosome 11 and schizophrenia in large samples from Europe.
    Mol Psychiatry. [Abstract] [Full-text]
40. Differential working memory performance as support for the Kraepelinian dichotomy between schizophrenia and bipolar disorder? An experimental neuropsychological study using circuit-specific working memory tasks.
    World J Biol Psychiatry. [Abstract] [Full-text]
41. Varenicline induces manic relapse in bipolar disorder.
    Gen Hosp Psychiatry. [Abstract] [Full-text]
42. Hemochromatosis-induced bipolar disorder: a case report.
    Gen Hosp Psychiatry. [Abstract] [Full-text]
43. Magnetic resonance imaging studies in unipolar depression: Systematic review and meta-regression analyses.
    Eur Neuropsychopharmacol. [Abstract] [Full-text]
44. The ZNF804A gene: characterization of a novel neural risk mechanism for the major psychoses.
    Neuropsychopharmacology, 36(9): 1871-8. [Abstract] [Full-text]
45. Hypersomnia in inter-episode bipolar disorder: does it have prognostic significance?
    J Affect Disord, 132(3): 438-44. [Abstract] [Full-text]
46. Neuroimaging-based markers of bipolar disorder: evidence from two meta-analyses.
    J Affect Disord, 132(3): 344-55. [Abstract] [Full-text]
47. The identification of unipolar mania subtype based on anxiety comorbidity.
    J Affect Disord, 132(3): 356-9. [Abstract] [Full-text]
48. Reduced long distance gamma (28-48 Hz) coherence in euthymic patients with bipolar disorder.
    J Affect Disord, 132(3): 325-32. [Abstract] [Full-text]
49. Increased DNA methylation status of the serotonin receptor 5HTR1A gene promoter in schizophrenia and bipolar disorder.
    J Affect Disord, 132(3): 450-3. [Abstract] [Full-text]
50. Sensitivity and specificity of the mood disorder questionnaire and the bipolar spectrum diagnostic scale in Argentinean patients with mood disorders.
    J Affect Disord, 132(3): 445-9. [Abstract] [Full-text]
51. Difference in Temperament and Character Inventory scores between depressed patients with bipolar II and unipolar major depressive disorders.
    J Affect Disord, 132(3): 319-24. [Abstract] [Full-text]
52. Identifying a cognitive impairment subgroup in adults with mood disorders.
    J Affect Disord, 132(3): 360-7. [Abstract] [Full-text]
53. Symptoms and behaviors prior to the first major affective episode of bipolar II disorder. An exploratory study.
    J Affect Disord, 132(3): 333-43. [Abstract] [Full-text]
54. Psychosocial and neurocognitive profiles in depressed patients with major depressive disorder and bipolar disorder.
    Psychiatry Res. [Abstract] [Full-text]
55. The activation of monocyte and T cell networks in patients with bipolar disorder.
    Brain Behav Immun, 25(6): 1206-13. [Abstract] [Full-text]
56. Increased risk-taking behavior in dopamine transporter knockdown mice: further support for a mouse model of mania.
    J Psychopharmacol, 25(7): 934-43. [Abstract] [Full-text]
57. TREM-1 and DAP12 expression in monocytes of patients with severe psychiatric disorders. EGR3, ATF3 and PU.1 as important transcription factors.
    Brain Behav Immun, 25(6): 1162-9. [Abstract] [Full-text]
58. Lithium differentially affects clock gene expression in serum-shocked NIH-3T3 cells.
    J Psychopharmacol, 25(7): 924-33. [Abstract] [Full-text]
59. Genome-wide linkage analysis of 972 bipolar pedigrees using single-nucleotide polymorphisms.
    Mol Psychiatry. [Abstract] [Full-text]
60. Creativity and executive function across manic, mixed and depressive episodes in bipolar I disorder.
    J Affect Disord. [Abstract] [Full-text]
61. Brief cognitive assessment instruments in schizophrenia and bipolar patients, and healthy control subjects: a comparison study between the Brief Cognitive Assessment Tool for Schizophrenia (B-CATS) and the Screen for Cognitive Impairment in Psychiatry (SCIP).
    Schizophr Res, 130(1): 137-42. [Abstract] [Full-text]
62. MMN/P3a deficits in first episode psychosis: comparing schizophrenia-spectrum and affective-spectrum subgroups.
    Schizophr Res, 130(1): 203-9. [Abstract] [Full-text]
63. Essential fatty acids and psychiatric disorders.
    Nutr Clin Pract, 26(4): 409-25. [Abstract] [Full-text]
64. Principal domains of quantitative anxiety trait in subjects with lifetime history of mania.
    J Affect Disord. [Abstract] [Full-text]
65. Physical health behaviours and health locus of control in people with schizophrenia-spectrum disorder and bipolar disorder: a cross-sectional comparative study with people with non-psychotic mental illness.
    BMC Psychiatry, 11: 104. [Abstract] [Full-text]
66. Endocrine and testicular changes induced by olanzapine in adult Wistar rats.
    J Appl Toxicol. [Abstract] [Full-text]
67. Bipolar mood disorder, creativity and schizotypy: an experimental study.
    Psychopathology, 44(5): 296-302. [Abstract] [Full-text]
68. Fronto-limbic dysfunction in mania pre-treatment and persistent amygdala over-activity post-treatment in pediatric bipolar disorder.
    Psychopharmacology (Berl), 216(4): 485-99. [Abstract] [Full-text]
69. Pharmacologic treatments for pediatric bipolar disorder: a review and meta-analysis.
    J Am Acad Child Adolesc Psychiatry, 50(8): 749-62.e39. [Abstract] [Full-text]
70. Prospective predictors of mood episodes in bipolar disorder.
    J Affect Disord. [Abstract] [Full-text]
71. Association between bipolar I disorder and the L55M and Q192R polymorphisms of the paraoxonase 1 (PON1) gene.
    J Affect Disord. [Abstract] [Full-text]
72. Sensory gating deficit is associated with catechol-O-methyltransferase polymorphisms in bipolar disorder.
    World J Biol Psychiatry, 12(5): 376-84. [Abstract] [Full-text]
73. Brain-derived neurotrophic factor as a state-marker of mood episodes in bipolar disorders: a systematic review and meta-regression analysis.
    J Psychiatr Res, 45(8): 995-1004. [Abstract] [Full-text]
74. Gender-specific lipid profiles in patients with bipolar disorder.
    J Psychiatr Res, 45(8): 1036-41. [Abstract] [Full-text]
75. Open adjunctive ziprasidone associated with weight loss in obese and overweight bipolar disorder patients.
    J Psychiatr Res, 45(8): 1128-32. [Abstract] [Full-text]
76. Altered sirtuin deacetylase gene expression in patients with a mood disorder.
    J Psychiatr Res, 45(8): 1106-12. [Abstract] [Full-text]
77. The characteristics of a discrete mood episode, neuro-cognitive impairment and re-hospitalization in bipolar disorder.
    J Psychiatr Res, 45(8): 1048-54. [Abstract] [Full-text]
78. Performance-based assessment of functional skills in severe mental illness: results of a large-scale study in China.
    J Psychiatr Res, 45(8): 1089-94. [Abstract] [Full-text]
79. The COMT and DRD3 genes interacted in bipolar I but not bipolar II disorder.
    World J Biol Psychiatry, 12(5): 385-91. [Abstract] [Full-text]
80. Bipolar Disorder and the TCI: Higher Self-Transcendence in Bipolar Disorder Compared to Major Depression.
    Depress Res Treat, 2011: 529638. [Abstract] [Full-text]
81. Unstable genes unstable mind: beyond the central dogma of molecular biology.
    Med Hypotheses, 77(2): 165-70. [Abstract] [Full-text]
82. Review of the safety, efficacy, and side effect profile of asenapine in the treatment of bipolar 1 disorder.
    Patient Prefer Adherence, 5: 333-41. [Abstract] [Full-text]
83. Prefrontal cortex glutathione S-transferase levels in patients with bipolar disorder, major depression and schizophrenia.
    Int J Neuropsychopharmacol, 14(8): 1069-74. [Abstract] [Full-text]
84. Effectiveness of psychotropic medications in the maintenance phase of bipolar disorder: a meta-analysis of randomized controlled trials.
    Int J Neuropsychopharmacol, 14(8): 1029-49. [Abstract] [Full-text]
85. Findings from bipolar offspring studies: methodology matters.
    Early Interv Psychiatry, 5(3): 181-91. [Abstract] [Full-text]
86. Is Ankyrin a genetic risk factor for psychiatric phenotypes?
    BMC Psychiatry, 11: 103. [Abstract] [Full-text]
87. Computerized testing of neurocognitive function in euthymic bipolar patients compared to those with mild cognitive impairment and cognitively healthy controls.
    Psychother Psychosom, 80(5): 298-303. [Abstract] [Full-text]
88. The neural basis of familial risk and temperamental variation in individuals at high risk of bipolar disorder.
    Biol Psychiatry, 70(4): 343-9. [Abstract] [Full-text]
89. The association of elevated body mass index with reduced brain volumes in first-episode mania.
    Biol Psychiatry, 70(4): 381-7. [Abstract] [Full-text]
90. Risky sexual behavior among patients in turkey with bipolar disorder, schizophrenia, and heroin addiction.
    J Sex Med, 8(8): 2284-91. [Abstract] [Full-text]
91. Trait-related decision-making impairment in the three phases of bipolar disorder.
    Biol Psychiatry, 70(4): 357-65. [Abstract] [Full-text]
92. White matter integrity in individuals at high genetic risk of bipolar disorder.
    Biol Psychiatry, 70(4): 350-6. [Abstract] [Full-text]
93. Evidence for antimanic efficacy of glycogen synthase kinase-3 (GSK3) inhibitors in a strain-specific model of acute mania.
    Int J Neuropsychopharmacol, 14(8): 1051-67. [Abstract] [Full-text]
94. Morphometric post-mortem studies in bipolar disorder: possible association with oxidative stress and apoptosis.
    Int J Neuropsychopharmacol, 14(8): 1075-89. [Abstract] [Full-text]
95. Brain-derived neurotrophic factor signalling mediates antidepressant effects of lamotrigine.
    Int J Neuropsychopharmacol, 14(8): 1091-8. [Abstract] [Full-text]
96. 3-Month Physical Activity Checklist: Development and validation with Taiwanese adults with mental illness.
    Int J Nurs Stud. [Abstract] [Full-text]
97. Evolution of promoter affinity for transcription factors in the human lineage.
    Mol Biol Evol, 28(8): 2173-83. [Abstract] [Full-text]
98. Episodes of Mood Disorders in 2,252 Pregnancies and Postpartum Periods.
    Am J Psychiatry. [Abstract] [Full-text]
99. Ziprasidone with adjunctive mood stabilizer in the maintenance treatment of bipolar I disorder: Long-term changes in weight and metabolic profiles.
    Eur Neuropsychopharmacol. [Abstract] [Full-text]
100. Comorbid anxiety disorders and baseline medication regimens predict clinical outcomes in individuals with co-occurring bipolar disorder and alcohol dependence: Results of a randomized controlled trial.
     Psychiatry Res, 188(3): 361-5. [Abstract] [Full-text]
101. Facial emotion perception in depression and bipolar disorder: a quantitative review.
     Psychiatry Res, 188(3): 303-9. [Abstract] [Full-text]
102. The kynurenine pathway in major depression: haplotype analysis of three related functional candidate genes.
     Psychiatry Res, 188(3): 355-60. [Abstract] [Full-text]
103. Memantine reduces mania-like symptoms in animal models.
     Psychiatry Res, 188(3): 366-71. [Abstract] [Full-text]

© 2004-2013 Bipolar Research Today. All Rights Reserved.